Bo M. Chen

No. 155, Nanjing North Street
Shenyang, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 66 publications

From State, Pathway, to Niche: The Ternary Network of Breast Cancer Stem-like Cells Driving Tumor Progression and Combination Therapy Prospects.

From State, Pathway, to Niche: The Ternary Network of Breast Cancer Stem-like Cells Driving Tumor Progression and Combination Therapy Prospects.

Journal: Biomolecules
Published: January 02, 2026

Blocking ubiquitination of hnRNPA1 maintains the self-renewal of breast cancer stem cells via mutually exclusive splicing of PKM pre-mRNA.

Blocking ubiquitination of hnRNPA1 maintains the self-renewal of breast cancer stem cells via mutually exclusive splicing of PKM pre-mRNA.

Journal: Oncogene
Published: September 26, 2025

Sentinel lymph node biopsy using dye alone in patients with initial clinical N1 breast cancer receiving neoadjuvant therapy: A multicenter diagnostic trial (Northern Breast Cancer Collaboration Group NBCG-002).

Sentinel lymph node biopsy using dye alone in patients with initial clinical N1 breast cancer receiving neoadjuvant therapy: A multicenter diagnostic trial (Northern Breast Cancer Collaboration Group NBCG-002).

Journal: Cancer
Published: August 27, 2025

Management and complication investigation among breast cancer patients undergoing immediate implant-based breast reconstruction: A Chinese multicenter study (CSBrS-012).

Management and complication investigation among breast cancer patients undergoing immediate implant-based breast reconstruction: A Chinese multicenter study (CSBrS-012).

Journal: Chinese medical journal
Published: July 11, 2025

Correction: SNORA47 affects stemness and chemotherapy sensitivity via EBF3/RPL11/c-Myc axis in luminal A breast cancer.

Correction: SNORA47 affects stemness and chemotherapy sensitivity via EBF3/RPL11/c-Myc axis in luminal A breast cancer.

Journal: Molecular medicine (Cambridge, Mass.)
Published: June 04, 2025

Prediction of neoadjuvant chemotherapy efficacy in patients with HER2-low breast cancer based on ultrasound radiomics.

Prediction of neoadjuvant chemotherapy efficacy in patients with HER2-low breast cancer based on ultrasound radiomics.

Journal: Cancer imaging : the official publication of the International Cancer Imaging Society
Published: April 18, 2025

Polyamine metabolism related gene index prediction of prognosis and immunotherapy response in breast cancer.

Polyamine metabolism related gene index prediction of prognosis and immunotherapy response in breast cancer.

Journal: Frontiers in oncology
Published: April 17, 2025

Radiomics analysis of contrast-free synthetic MRI and apparent diffusion coefficient for early predicting neoadjuvant chemotherapy response in breast cancer.

Radiomics analysis of contrast-free synthetic MRI and apparent diffusion coefficient for early predicting neoadjuvant chemotherapy response in breast cancer.

Journal: European journal of radiology
Published: November 11, 2024

SNORA47 affects stemness and chemotherapy sensitivity via EBF3/RPL11/c-Myc axis in luminal A breast cancer.

SNORA47 affects stemness and chemotherapy sensitivity via EBF3/RPL11/c-Myc axis in luminal A breast cancer.

Journal: Molecular medicine (Cambridge, Mass.)
Published: November 09, 2024

De-escalated neoadjuvant weekly nab-paclitaxel with trastuzumab and pertuzumab versus docetaxel, carboplatin, trastuzumab, and pertuzumab in patients with HER2-positive early breast cancer (HELEN-006): a multicentre, randomised, phase 3 trial.

De-escalated neoadjuvant weekly nab-paclitaxel with trastuzumab and pertuzumab versus docetaxel, carboplatin, trastuzumab, and pertuzumab in patients with HER2-positive early breast cancer (HELEN-006): a multicentre, randomised, phase 3 trial.

Journal: The Lancet. Oncology
Published: July 11, 2024

The features of male breast cancer in China: A real-world study.

The features of male breast cancer in China: A real-world study.

Journal: Breast (Edinburgh, Scotland)
Published: May 09, 2024

When will the immune-stimulating antibody conjugates (ISACs) be transferred from bench to bedside?

When will the immune-stimulating antibody conjugates (ISACs) be transferred from bench to bedside?

Journal: Pharmacological research
Published: January 21, 2024
Showing 1-12 of 66

Last Updated: 09/26/2026